Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.
Community Practice Connections™: Bridging Clinical Gaps and Disparities in Care in TNBC
Release Date: December 23, 2021
Expiration Date: December 23, 2022
Activity Overview
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Examine strategies to overcome racial disparities in diagnosis, treatment, and survival outcomes for patients with triple-negative breast cancer (TNBC)
- Explain biology- and environment-related factors underlying the increased risk of mortality for African American women with TNBC
- Assess efficacy and safety data from pivotal trials evaluating current and emerging therapies for TNBC
- Apply practice-changing data to case scenarios of patients with TNBC across racial, ethnic, and socioeconomic backgrounds, with a focus on clinician and patient education
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
Chair:

Director, Breast Cancer Research Program
Associate Professor, Harvard Medical School
Attending Physician, Medical Oncology, Massachusetts General Hospital
Boston, MA
Disclosures: Grant/Research Support: Daiichi Pharma/Astra Zeneca, Genentech, Immunomedics, Merck, Natera, Novartis, Pfizer, Radius Health, Sanofi. Consultant: Biotheranostics Inc., Daiichi Pharma/Astra Zeneca, Eli Lilly, Foundation Medicine, Genentech, Immunomedics, Merck, Novartis, Pfizer, Phillips, Puma Biotechnology, Radius Health, Sanofi, Taiho Pharmaceutical.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.


